Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

India · Delayed Price · Currency is INR

130.28

-5.26 (-3.88%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Agriculture Activities	3.19B	2.97B	2.72B	2.56B	2.41B
Agriculture Activities Growth	7.56%	9.21%	6.38%	6.18%	10.71%
Trading Activities	456.05M	357.66M	295.37M	228.41M	301.38M
Trading Activities Growth	27.51%	21.09%	29.31%	-24.21%	4.34%
Total	3.65B	3.33B	3.01B	2.78B	2.71B
Total Growth	9.71%	10.37%	8.26%	2.80%	9.97%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	3.60B	3.28B	2.93B	2.78B	3.06B
India Growth	9.78%	11.92%	5.36%	-9.07%	11.78%
Outside India	45.57M	43.81M	80.78M	-	14.46M
Outside India Growth	4.02%	-45.77%	-	-	-76.07%
Total	3.65B	3.33B	3.01B	2.78B	3.08B
Total Growth	9.71%	10.37%	8.26%	-9.49%	9.89%

Source: S&P Global Market Intelligence.